Purdue Pharma Shuts Down — $7.4 Billion Settlement Secured
RedMap Risk Score
90/100
CRITICAL RISK
Risk Signal Summary
New York Attorney General Letitia James announced the shutdown of Purdue Pharma as part of a $7.4 billion settlement with the Sackler family, who are barred from selling opioids in the U.S. A new public benefit corporation, Knoa Pharma, will replace Purdue and focus on public health.
Why This Matters
Governance and compliance anomalies in organizations managing public funds or charitable assets directly affect donors, beneficiaries, and taxpayers. The risk indicators identified in this report warrant further scrutiny by regulators, donors, and oversight bodies.
Create a free account
Unlimited access to all articles · No daily limit
No credit card · Instant access
Multiple related entities detected
🔒 Purdue Pharma has potential risk indicators with connected organizations. Unlock full network analysis.
Sign up free to unlock →Disclaimer: This report identifies risk indicators and unusual financial patterns based on publicly available IRS Form 990 data and government enforcement records. It does not assert fraud, criminal conduct, or legal violations. All findings are for informational purposes only and should not be construed as legal or financial advice.
Share this finding
You just analyzed Purdue Pharma — Risk Score 90/100, $7.4B involved. Share this with your network.
Post text is pre-formatted for maximum reach — you can edit before posting.
Discover more risk signals across the USA.